Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind trial of indometacin cataplasm for knee osteoarthritis
CTR20254039Phase 3Active
- Sponsor
- Hainan Huiyuantang Pharmaceutical
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indomethacin in knee osteoarthritis (OA), sponsored by Hainan Huiyuantang Pharmaceutical. Started Nov 2025; status: active.
02
Drugs
indomethacin
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20254039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254039.